6009 POSTER DISCUSSION Progression Free and Overall Survival After Neoadjuvant Treatment of Colorectal Liver Metastases With Cetuximab Plus FOLFOX or FOLFIRI – Results of the CELIM Study
- DOI
- 10.1016/s0959-8049(11)71654-9
- Published
- 2011-09
- Container
- European Journal of Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0959-8049-11-71654-9,
title = {6009 POSTER DISCUSSION Progression Free and Overall Survival After Neoadjuvant Treatment of Colorectal Liver Metastases With Cetuximab Plus FOLFOX or FOLFIRI – Results of the CELIM Study},
author = {G. Folprecht and T. Gruenberger and W. Bechstein and T. Lordick and H. Lang and J. Weitz and T. Suedhoff and J. Hartmann and T. Liersch and C. Koehne},
year = {2011},
journal = {European Journal of Cancer},
doi = {10.1016/s0959-8049(11)71654-9},
url = {https://doi.org/10.1016/s0959-8049(11)71654-9}
}RIS
TY - JOUR TI - 6009 POSTER DISCUSSION Progression Free and Overall Survival After Neoadjuvant Treatment of Colorectal Liver Metastases With Cetuximab Plus FOLFOX or FOLFIRI – Results of the CELIM Study AU - G. Folprecht AU - T. Gruenberger AU - W. Bechstein AU - T. Lordick AU - H. Lang AU - J. Weitz AU - T. Suedhoff AU - J. Hartmann AU - T. Liersch AU - C. Koehne PY - 2011 JO - European Journal of Cancer DO - 10.1016/s0959-8049(11)71654-9 UR - https://doi.org/10.1016/s0959-8049(11)71654-9 ER -
APA
Folprecht, G., Gruenberger, T., Bechstein, W., Lordick, T., Lang, H., Weitz, J., Suedhoff, T., Hartmann, J., Liersch, T., & Koehne, C. (2011). 6009 POSTER DISCUSSION Progression Free and Overall Survival After Neoadjuvant Treatment of Colorectal Liver Metastases With Cetuximab Plus FOLFOX or FOLFIRI – Results of the CELIM Study. European Journal of Cancer. https://doi.org/10.1016/s0959-8049(11)71654-9
Source records
- crossref · retrieved 2026-09-26T11:17:36.026Z